Handelen Merck KGaA - EUR - MRKd CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Spread | 0.65 | ||||||||
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.024161% | ||||||||
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | -0.020283% | ||||||||
Tijd van overnight-tarief | 22:00 (UTC) | ||||||||
Min. verhandelde hoeveelheid | 1 | ||||||||
Valuta | EUR | ||||||||
Marge | 20% | ||||||||
Effectenbeurs | Germany | ||||||||
Handelscommissie | 0% |
*Information provided by Capital.com
Merck KGaA ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Prev. Close* | 182 |
Open* | 184.85 |
1-Jaarlijkse Verandering* | -2.97% |
Dagelijks bereik* | 181.35 - 185.4 |
52 wekelijks bereik | 153.10-202.80 |
Weekgemiddelde volume (10 dagen) | 304.81K |
Gemiddeld volume (3 maanden) | 6.16M |
Marktkapitalisatie | 23.61B |
P/E Ratio | 22.89 |
Uitstaande Aandelen | 434.78M |
Omzet | 21.79B |
EPS | 7.98 |
Dividend (opbrengst %) | 1.01287 |
Beta | 0.58 |
Volgende inkomsten datum | Mar 2, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
---|---|---|---|---|---|---|
Feb 7, 2023 | 182.00 | -0.85 | -0.46% | 182.85 | 185.40 | 181.40 |
Feb 6, 2023 | 184.25 | -0.30 | -0.16% | 184.55 | 186.55 | 184.15 |
Feb 3, 2023 | 185.80 | 3.60 | 1.98% | 182.20 | 186.25 | 181.00 |
Feb 2, 2023 | 183.70 | 4.20 | 2.34% | 179.50 | 184.80 | 179.45 |
Feb 1, 2023 | 181.80 | -7.00 | -3.71% | 188.80 | 188.85 | 181.10 |
Jan 31, 2023 | 190.75 | -2.60 | -1.34% | 193.35 | 193.55 | 189.65 |
Jan 30, 2023 | 193.60 | 4.10 | 2.16% | 189.50 | 194.05 | 188.95 |
Jan 27, 2023 | 190.05 | -1.40 | -0.73% | 191.45 | 191.90 | 189.55 |
Jan 26, 2023 | 192.30 | -1.90 | -0.98% | 194.20 | 195.45 | 192.30 |
Jan 25, 2023 | 190.45 | 1.65 | 0.87% | 188.80 | 191.00 | 187.15 |
Jan 24, 2023 | 189.45 | -2.55 | -1.33% | 192.00 | 192.75 | 188.80 |
Jan 23, 2023 | 192.55 | 3.30 | 1.74% | 189.25 | 193.05 | 188.45 |
Jan 20, 2023 | 186.55 | -1.80 | -0.96% | 188.35 | 191.20 | 186.50 |
Jan 19, 2023 | 189.35 | -1.50 | -0.79% | 190.85 | 191.00 | 186.80 |
Jan 18, 2023 | 192.35 | -3.95 | -2.01% | 196.30 | 196.40 | 192.15 |
Jan 17, 2023 | 196.00 | -2.70 | -1.36% | 198.70 | 198.75 | 195.40 |
Jan 16, 2023 | 199.20 | 1.15 | 0.58% | 198.05 | 200.00 | 197.85 |
Jan 13, 2023 | 197.65 | 2.45 | 1.26% | 195.20 | 197.75 | 193.15 |
Jan 12, 2023 | 196.75 | -3.15 | -1.58% | 199.90 | 200.30 | 192.85 |
Jan 11, 2023 | 200.70 | 6.95 | 3.59% | 193.75 | 202.20 | 193.55 |
Merck KGaA - EUR Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Jaarlijks
- Per kwartaal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Totale inkomsten | 15024 | 14517 | 14836 | 16152 | 17534 | 19687 |
Inkomsten | 15024 | 14517 | 14836 | 16152 | 17534 | 19687 |
Kosten van opbrengsten, totaal | 5201 | 5071 | 5342 | 5951 | 6782 | 7325 |
Brutowinst | 9823 | 9446 | 9494 | 10201 | 10752 | 12362 |
Totale bedrijfskosten | 12543 | 12094 | 13109 | 14032 | 14549 | 15508 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 4409 | 4234 | 4256 | 4686 | 4600 | 4855 |
Onderzoek & Ontwikkeling | 1972 | 2102 | 2220 | 2239 | 2262 | 2400 |
Depreciation / Amortization | 1036 | 1020 | 979 | 923 | 636 | 589 |
Rentekosten (inkomsten) - Operationeel nettobedrijfsresultaat | 57 | 3 | 62 | 1 | ||
Ongebruikelijke uitgaven (inkomsten) | -46 | -26 | 339 | 389 | 85 | 184 |
Other Operating Expenses, Total | -86 | -310 | -89 | -156 | 184 | 154 |
Bedrijfsresultaat | 2481 | 2423 | 1727 | 2120 | 2985 | 4179 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | -274 | -243 | -209 | -338 | -350 | -255 |
Overige, Netto | -53 | -51 | -57 | -47 | -5 | 0 |
Netto inkomen voor belastingen | 2154 | 2129 | 1461 | 1735 | 2630 | 3924 |
Netto inkomen na belastingen | 1633 | 2557 | 1093 | 1295 | 1993 | 3065 |
Minderheidsbelang | -4 | -10 | -22 | -3 | -7 | -10 |
Netto inkomen voor extra. Posten | 1629 | 2547 | 1071 | 1292 | 1986 | 3055 |
Totale buitengewone posten | 0 | 57 | 2303 | 28 | 0 | |
Netto inkomen | 1629 | 2604 | 3374 | 1320 | 1986 | 3055 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 1629 | 2548 | 1071 | 1292 | 1987 | 3055 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 1629 | 2605 | 3374 | 1320 | 1987 | 3055 |
Verwaterd Netto Inkomen | 1629 | 2605 | 3374 | 1320 | 1987 | 3055 |
Verwaterd Gewogen Gemiddelde Aandelen | 434.778 | 434.778 | 434.794 | 434.211 | 434.792 | 434.566 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 3.74674 | 5.86046 | 2.46324 | 2.97552 | 4.57 | 7.03 |
Dividends per Share - Common Stock Primary Issue | 1.2 | 1.25 | 1.25 | 1.3 | 1.4 | 1.85 |
Verwaterde Genormaliseerde Winst per Aandeel | 3.66653 | 5.91727 | 3.04653 | 3.6442 | 4.71815 | 7.36072 |
Total Adjustments to Net Income | 1 | 0 | 1 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Totale inkomsten | 4631 | 4870 | 4973 | 5213 | 5198 |
Inkomsten | 4631 | 4870 | 4973 | 5213 | 5198 |
Kosten van opbrengsten, totaal | 1721 | 1813 | 1859 | 1959 | 1987 |
Brutowinst | 2910 | 3057 | 3114 | 3254 | 3211 |
Totale bedrijfskosten | 3588 | 3821 | 3926 | 4174 | 4025 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 1280 | 1342 | 1376 | 1546 | 1374 |
Onderzoek & Ontwikkeling | 574 | 585 | 660 | 590 | 586 |
Ongebruikelijke uitgaven (inkomsten) | 6 | 0 | -1 | -6 | 5 |
Other Operating Expenses, Total | 7 | 81 | 32 | 85 | 73 |
Bedrijfsresultaat | 1043 | 1049 | 1047 | 1039 | 1173 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | -60 | -95 | -54 | -47 | -34 |
Overige, Netto | 1 | 1 | |||
Netto inkomen voor belastingen | 984 | 955 | 993 | 992 | 1139 |
Netto inkomen na belastingen | 748 | 747 | 764 | 806 | 884 |
Minderheidsbelang | -1 | -2 | -3 | -4 | -3 |
Netto inkomen voor extra. Posten | 747 | 745 | 761 | 802 | 881 |
Netto inkomen | 747 | 745 | 761 | 802 | 881 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 747 | 745 | 761 | 802 | 880 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 747 | 745 | 761 | 802 | 880 |
Verwaterd Netto Inkomen | 747 | 745 | 761 | 802 | 880 |
Verwaterd Gewogen Gemiddelde Aandelen | 434.302 | 434.778 | 434.857 | 433.438 | 435.644 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 1.72 | 1.71352 | 1.75 | 1.85032 | 2.02 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 1.85 | 0 |
Verwaterde Genormaliseerde Winst per Aandeel | 1.80927 | 1.90422 | 1.8827 | 1.80908 | 2.07345 |
Total Adjustments to Net Income | 0 | -1 |
- Jaarlijks
- Per kwartaal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Totaal vlottende activa | 7670 | 7455 | 9236 | 9003 | 9280 | 10982 |
Geldmiddelen en kortetermijnbeleggingen | 981 | 623 | 2199 | 598 | 1234 | 1685 |
Geldmiddelen & Equivalenten | 662 | 481 | 779 | 541 | 1109 | 1511 |
Korte Termijn Investeringen | 319 | 142 | 1420 | 57 | 125 | 174 |
Totale Vorderingen, Netto | 3607 | 3707 | 3738 | 4233 | 3910 | 4345 |
Accounts Receivable - Trade, Net | 2888 | 2923 | 3278 | 3644 | 3390 | 3853 |
Total Inventory | 2609 | 2632 | 2764 | 3342 | 3294 | 3900 |
Prepaid Expenses | 276 | 338 | 435 | 493 | 519 | 570 |
Other Current Assets, Total | 197 | 155 | 100 | 337 | 323 | 482 |
Total Assets | 38258 | 35621 | 36888 | 43811 | 41796 | 45362 |
Property/Plant/Equipment, Total - Net | 4231 | 4512 | 4811 | 6213 | 6421 | 7217 |
Property/Plant/Equipment, Total - Gross | 9404 | 9853 | 10551 | 12561 | 13228 | 14810 |
Accumulated Depreciation, Total | -5172 | -5340 | -5740 | -6348 | -6808 | -7593 |
Goodwill, Net | 15015 | 13582 | 13764 | 17141 | 15959 | 17004 |
Intangibles, Net | 9980 | 8317 | 7237 | 9175 | 7653 | 7612 |
Long Term Investments | 191 | 419 | 1 | 3 | ||
Note Receivable - Long Term | 15 | 41 | 614 | 746 | 830 | 922 |
Other Long Term Assets, Total | 1156 | 1295 | 1226 | 1533 | 1652 | 1622 |
Total Current Liabilities | 9089 | 8635 | 8517 | 11842 | 9231 | 10432 |
Accounts Payable | 2048 | 2195 | 1766 | 2054 | 1768 | 2380 |
Accrued Expenses | 603 | 778 | 799 | 791 | 975 | 1204 |
Notes Payable/Short Term Debt | 1855 | 1173 | 982 | 2224 | 515 | 1434 |
Current Port. of LT Debt/Capital Leases | 1908 | 1590 | 1217 | 2307 | 1780 | 1062 |
Other Current Liabilities, Total | 2675 | 2899 | 3753 | 4466 | 4193 | 4352 |
Total Liabilities | 24269 | 21618 | 19688 | 25945 | 24850 | 24024 |
Total Long Term Debt | 8706 | 7947 | 6608 | 8588 | 9745 | 8270 |
Long Term Debt | 8706 | 7947 | 6608 | 8130 | 9418 | 7928 |
Deferred Income Tax | 2724 | 1489 | 1288 | 1828 | 1441 | 1411 |
Minority Interest | 61 | 63 | 33 | 48 | 71 | 78 |
Other Liabilities, Total | 3689 | 3484 | 3242 | 3639 | 4362 | 3833 |
Total Equity | 13989 | 14003 | 17200 | 17866 | 16946 | 21338 |
Preferred Stock - Non Redeemable, Net | 397 | 397 | 397 | 397 | 397 | 397 |
Common Stock | 168 | 168 | 168 | 168 | 168 | 168 |
Additional Paid-In Capital | 3814 | 3814 | 3814 | 3814 | 3814 | 3814 |
Retained Earnings (Accumulated Deficit) | 8049 | 9902 | 12532 | 13236 | 14556 | 16673 |
Other Equity, Total | 1561 | -278 | 289 | 251 | -1989 | 286 |
Total Liabilities & Shareholders’ Equity | 38258 | 35621 | 36888 | 43811 | 41796 | 45362 |
Total Common Shares Outstanding | 434.778 | 434.778 | 434.778 | 434.778 | 434.778 | 434.778 |
Capital Lease Obligations | 458 | 327 | 342 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Totaal vlottende activa | 10617 | 10182 | 10315 | 10982 | 11085 |
Geldmiddelen en kortetermijnbeleggingen | 2298 | 1870 | 1665 | 2073 | 1445 |
Geldmiddelen & Equivalenten | 2238 | 1825 | 1523 | 1899 | 1339 |
Korte Termijn Investeringen | 60 | 45 | 142 | 174 | 106 |
Totale Vorderingen, Netto | 4226 | 4124 | 4207 | 4345 | 4705 |
Accounts Receivable - Trade, Net | 3816 | 3771 | 3930 | 3853 | 4345 |
Total Inventory | 3462 | 3564 | 3760 | 3900 | 4143 |
Other Current Assets, Total | 631 | 624 | 683 | 664 | 792 |
Total Assets | 43891 | 43145 | 43836 | 45362 | 46235 |
Property/Plant/Equipment, Total - Net | 6552 | 6601 | 6761 | 7217 | 7303 |
Goodwill, Net | 16541 | 16347 | 16670 | 17004 | 17761 |
Intangibles, Net | 7765 | 7613 | 7628 | 7612 | 7549 |
Long Term Investments | 770 | 744 | 794 | 914 | 905 |
Note Receivable - Long Term | 38 | 39 | 39 | 35 | 35 |
Other Long Term Assets, Total | 1608 | 1619 | 1629 | 1598 | 1597 |
Total Current Liabilities | 10652 | 9820 | 9793 | 10432 | 10207 |
Accounts Payable | 1937 | 2107 | 2132 | 2380 | 2356 |
Accrued Expenses | 118 | 144 | 191 | 224 | 174 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 3347 | 3278 | 2770 | 2531 | 2345 |
Other Current Liabilities, Total | 5250 | 4291 | 4700 | 5297 | 5332 |
Total Liabilities | 24975 | 23852 | 23229 | 24024 | 23316 |
Total Long Term Debt | 9001 | 8721 | 8195 | 8270 | 8286 |
Long Term Debt | 9001 | 8721 | 8195 | 8270 | 8286 |
Deferred Income Tax | 1440 | 1401 | 1374 | 1411 | 1389 |
Minority Interest | 67 | 68 | 72 | 78 | 71 |
Other Liabilities, Total | 3815 | 3842 | 3795 | 3833 | 3363 |
Total Equity | 18916 | 19293 | 20607 | 21338 | 22919 |
Preferred Stock - Non Redeemable, Net | 397 | 397 | 397 | 397 | |
Common Stock | 168 | 168 | 168 | 168 | 565 |
Additional Paid-In Capital | 3814 | 3814 | 3814 | 3814 | 3814 |
Retained Earnings (Accumulated Deficit) | 15240 | 15799 | 16556 | 16673 | 18540 |
Other Equity, Total | -703 | -885 | -328 | 286 | |
Total Liabilities & Shareholders’ Equity | 43891 | 43145 | 43836 | 45362 | 46235 |
Total Common Shares Outstanding | 434.778 | 434.778 | 434.778 | 434.778 | 434.778 |
- Jaarlijks
- Per kwartaal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Netto-inkomen/Beginsaldo | 1633 | 2615 | 3396 | 1324 | 1994 | 3065 |
Geldmiddelen uit Operationele Activiteiten | 2510 | 2696 | 2219 | 2856 | 3477 | 4616 |
Geldmiddelen uit Operationele Activiteiten | 1934 | 1758 | 1812 | 1944 | 1938 | 1762 |
Niet-Geldelijke Posten | -488 | -250 | -2523 | 149 | -59 | 62 |
Veranderingen in het Operationeel Kapitaal | -569 | -1427 | -466 | -561 | -396 | -273 |
Geldmiddelen uit Investeringsactiviteiten | -503 | -1147 | 2191 | -6153 | -1340 | -1578 |
Kapitaaluitgaven | -848 | -1311 | -1016 | -1021 | -1563 | -1421 |
Overige Cash Flow investeringsposten, Totaal | 345 | 164 | 3207 | -5132 | 223 | -157 |
Geldmiddelen uit Financieringsactiviteiten | -1908 | -1870 | -2825 | 1902 | -1522 | -2504 |
Financiering van Cash Flow Posten | -464 | -469 | -607 | -527 | -519 | -576 |
Total Cash Dividends Paid | -136 | -155 | -162 | -162 | -168 | -181 |
Uitgifte (Aflossing) van Schulden, Netto | -1308 | -1246 | -2056 | 2591 | -835 | -1747 |
Wisselkoerseffecten | 8 | -30 | -5 | 5 | -40 | 9 |
Nettowijziging in Geldmiddelen | 107 | -351 | 1580 | -1390 | 575 | 543 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 748 | 1495 | 2258 | 3065 | 884 |
Cash From Operating Activities | 1216 | 2104 | 3571 | 4616 | 840 |
Cash From Operating Activities | 424 | 843 | 1287 | 1762 | 430 |
Non-Cash Items | 6 | 25 | 46 | 62 | -24 |
Changes in Working Capital | 38 | -259 | -20 | -273 | -450 |
Cash From Investing Activities | -346 | -587 | -1226 | -1578 | -1089 |
Capital Expenditures | -362 | -638 | -1155 | -1421 | -498 |
Other Investing Cash Flow Items, Total | 16 | 51 | -71 | -157 | -591 |
Cash From Financing Activities | 6 | -1054 | -2184 | -2504 | -315 |
Financing Cash Flow Items | -55 | -575 | -575 | -576 | -100 |
Total Cash Dividends Paid | 0 | -181 | -181 | -181 | 0 |
Issuance (Retirement) of Debt, Net | 61 | -298 | -1428 | -1747 | -215 |
Foreign Exchange Effects | 7 | 6 | 7 | 9 | 4 |
Net Change in Cash | 883 | 469 | 168 | 543 | -560 |
Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.8422 | 8842949 | 0 | 2022-09-27 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 4.84 | 6255325 | 3997581 | 2022-09-27 | LOW |
Fidelity International | Investment Advisor | 3.0193 | 3902150 | 2587266 | 2022-09-19 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 2.9271 | 3783100 | -924069 | 2022-05-18 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 2.8682 | 3706864 | -407104 | 2022-12-14 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.8079 | 3629024 | 3672 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.3464 | 3032598 | 488031 | 2022-12-31 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 1.9124 | 2471640 | 83238 | 2022-12-31 | LOW |
FMR Investment Management (U.K.) Limited | Investment Advisor | 1.3005 | 1680776 | -5936 | 2022-12-31 | LOW |
Deka Investment GmbH | Investment Advisor/Hedge Fund | 1.1334 | 1464775 | -25955 | 2022-12-31 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 1.1038 | 1426513 | 15622 | 2022-12-31 | LOW |
Allianz Global Investors GmbH | Investment Advisor | 1.0531 | 1361000 | -28942 | 2022-11-30 | LOW |
Union Investment Privatfonds GmbH | Investment Advisor | 0.9614 | 1242564 | 560959 | 2022-09-30 | LOW |
Eleva Capital SAS | Investment Advisor | 0.8919 | 1152665 | 25800 | 2022-10-31 | HIGH |
MFS International Singapore Pte. Ltd | Investment Advisor | 0.8661 | 1119411 | -22611 | 2022-12-31 | LOW |
BNP Paribas Asset Management France SAS | Investment Advisor/Hedge Fund | 0.8255 | 1066840 | -1655 | 2022-12-31 | LOW |
Lazard Asset Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7985 | 1031971 | -21628 | 2022-12-31 | LOW |
Walter Scott & Partners Ltd. | Investment Advisor/Hedge Fund | 0.7724 | 998279 | 69355 | 2023-01-31 | LOW |
J O Hambro Capital Management Limited | Investment Advisor/Hedge Fund | 0.7686 | 993311 | -119431 | 2022-09-30 | MED |
California Public Employees' Retirement System | Pension Fund | 0.7543 | 974843 | -146711 | 2021-06-30 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com GroupHandelaren
Actieve klanten per maand
Maandelijks beleggingsvolume
Opgenomen per maand
Handelscalculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Merck - EUR Company profile
Over Merck KGaA - EUR
Merck KGaA is een in Duitsland gevestigd wetenschaps- en technologiebedrijf. Het bedrijf is actief in drie bedrijfssegmenten: Gezondheidszorg, Biowetenschappen en Elektronica. De Healthcare business, die in de Verenigde Staten en Canada actief is als EMD Serono, richt zich op therapeutische gebieden zoals allergieën, vruchtbaarheid, oncologie en neurodegeneratieve ziekten, en ontwikkelt geneesmiddelen, diagnostische stoffen en medische apparatuur. De divisie Life Sciences omvat de activiteiten van MilliporeSigma, dat oplossingen biedt die biotechnologisch en farmaceutisch onderzoek vergemakkelijken. Het productengamma omvat onder meer laboratoriumwatersystemen, gene editing tools, cellijnen en end-to-end medicijnproductiesystemen. De Electronics business maakt digitaal leven mogelijk en levert gespecialiseerde chemicaliën voor diverse toepassingen, waaronder vloeibare kristallen voor elektronische beeldschermen, materialen voor geïntegreerde circuits, effectpigmenten voor coatings en kleurcosmetica, alsook functionele materialen voor energieoplossingen.
Industry: | Proprietary & Advanced Pharmaceuticals |
Frankfurter Str. 250
DARMSTADT
HESSEN 64293
DE
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 500.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen